Torrent to acquire KKR’s stake in JB Pharma for US$1.4 billion
Torrent Pharmaceuticals agreed to take a controlling stake in JB Chemicals & Pharmaceuticals from private equity firm KKR, the latest ...
Tag: Pharma
US pharma tariffs would raise US drug costs by US$51 billion annually, report finds
A 25 per cent US tariff on pharmaceutical imports would increase US drug costs by nearly US$51 billion annually, boosting ...
Bain is said to near 500 billion yen deal for Mitsubishi pharma unit
BAIN Capital is nearing a deal to buy Mitsubishi Chemical Group’s pharmaceutical unit, sources familiar with the matter said, adding ...
Bain is said to near 500 billion yen deal for Mitsubishi pharma unit
BAIN Capital is nearing a deal to buy Mitsubishi Chemical Group’s pharmaceutical unit, sources familiar with the matter said, adding ...
Lundbeck to buy Longboard Pharma in US$2.6 billion deal
Lundbeck is offering shareholders in the US company Longboard US$60 per share in cashH Lundbeck agreed to acquire Longboard Pharmaceuticals ...
China’s WuXi explores sale of pharma operations as US restrictions loom: FT
WUXI AppTec and WuXi Biologics are planning to sell some of their operations after the Chinese biotech companies were targeted ...
Enhancing Pharma Industry’s Patient Program Capabilities with Advanced Master Data Management Application
Patient programs are crucial in the pharmaceutical industry as they promote patient adherence, offer education, and enhance overall health outcomes. ...
US Supreme Court blocks Purdue Pharma bankruptcy settlement
THE US Supreme Court on Thursday (Jun 27) blocked OxyContin maker Purdue Pharma’s bankruptcy settlement that would have shielded its ...
Kobayashi Pharma ordered to recall red yeast rice pills after 2 deaths
JAPANESE authorities on Wednesday (Mar 27) ordered drugmaker Kobayashi Pharmaceutical to recall three dietary supplement products containing red yeast rice, ...
AstraZeneca bets on new cancer treatments with US$2 billion Fusion Pharma purchase
ASTRAZENECA said on Tuesday (Mar 19) it will buy clinical-stage biopharmaceutical company Fusion Pharmaceuticals for about US$2 billion in cash ...
Forbes 40under40 stands as a distinguished platform revered for its commitment to honoring and applauding the remarkable achievements of exceptional individuals who have yet to reach the age of 40. This esteemed initiative serves as a beacon of inspiration, spotlighting trailblazers across various industries and domains, showcasing their innovation, leadership, and impact on a global scale.
© 2025 Forbes 40under40. All Rights Reserved.